Rock Springs Capital Management LP - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$22,221,000
+61.4%
3,685,000
-3.7%
0.70%
+27.9%
Q3 2019$13,770,000
+74.2%
3,825,000
+29.7%
0.55%
+92.0%
Q2 2019$7,906,000
-1.1%
2,950,000
+9.3%
0.29%
-7.1%
Q1 2019$7,992,000
+116.2%
2,700,000
+16.1%
0.31%
+76.0%
Q4 2018$3,697,000
-58.1%
2,325,000
-3.1%
0.18%
-45.3%
Q3 2018$8,832,000
+32.8%
2,400,000
+2.1%
0.32%
+25.0%
Q2 2018$6,651,000
-20.3%
2,350,000
+4.4%
0.26%
-28.1%
Q1 2018$8,348,000
+28.8%
2,250,0000.0%0.36%
+21.1%
Q4 2017$6,480,000
-32.3%
2,250,000
+5.6%
0.29%
-33.5%
Q3 2017$9,570,000
+20.9%
2,131,400
+23.6%
0.44%
+10.5%
Q2 2017$7,918,000
+25.4%
1,725,000
+15.0%
0.40%
+9.9%
Q1 2017$6,315,000
+11.2%
1,500,000
+9.1%
0.36%
-4.2%
Q4 2016$5,679,000
-46.7%
1,375,000
+4.5%
0.38%
-43.1%
Q3 2016$10,660,000
+4.1%
1,316,000
+0.3%
0.67%
-11.9%
Q2 2016$10,238,000
+8.7%
1,312,500
+7.6%
0.76%
-3.9%
Q1 2016$9,418,000
-21.0%
1,220,000
+10.4%
0.79%
-12.6%
Q4 2015$11,923,000
+53.4%
1,105,000
-1.8%
0.90%
+43.1%
Q3 2015$7,774,000
-20.2%
1,125,000
+2.3%
0.63%
-11.3%
Q2 2015$9,746,000
+64.7%
1,100,000
+83.3%
0.71%
+28.6%
Q1 2015$5,916,000
+32.3%
600,000
+64.4%
0.55%
+5.7%
Q4 2014$4,471,000365,0000.52%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders